MacroGenics Surpasses Expectations with Q3 Profits

MacroGenics Q3 financials exceed expectations, with a net income of $16.8 million and revenue of $72.8 million, surpassing analysts predictions of a loss and a revenue of $28.3 million. This positive performance indicates a successful quarter for the biopharmaceutical firm.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.